Talaris Therapeutics Announces Addition to the Nasdaq Biotechnology Index
BOSTON and LOUISVILLE, Ky., Dec. 20, 2023 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc., (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases,…